In 2023, the production value of basic pharmaceutical products in Switzerland stood at 29.05 billion Euros. The forecasted data from 2024 to 2028 shows a steady increase in production value. Year-on-year percentages indicate a consistent upward trend: 5.4% in 2024, 5.3% in 2025, 5.0% in 2026, 4.7% in 2027, and 4.5% in 2028. Over the five-year period, the compounded annual growth rate (CAGR) is 5.0%.
Future trends to watch for include the impact of technological advancements in pharmaceutical manufacturing, regulatory changes, and global competitive dynamics. Additionally, the increasing focus on biopharmaceuticals could significantly influence production values.
